Comparing 150cm OAGB With 150cm Biliopancreatic Limb RYGB. A Non-inferiority Trial
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorFlevoziekenhuis
About this trial
The purpose of this study is to assess the safety and efficiency of OAGB compared to RYGB
Eligibility criteria
Qualifiers
body-mass index (BMI) of 40 kg/m2 or higher, or 35 kg/m2 or higher with the presence of at least one comorbidity (type 2 diabetes, high blood pressure, obstructive sleep apnoea, dyslipidaemia, osteoarthritis of the hip or knee)
a positive evaluation by our BMDT
Disqualifiers
Presence of H. Pylori, resistant to eradication therapy
chronic diarrhoea
history of previous bariatric or extensive abdominal surgery
Trial design
Treatments tested in this trial
- OAGB
- RYGB
Treatment groups
298 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov